BioCentury
ARTICLE | Company News

Swiss Federal Institute of Technology other research news

March 4, 2002 8:00 AM UTC

Researchers published in Nature Biotechnology evidence that single chain antibody fragments can be used to target IL-12 to the site of tumors, induce inflammatory infiltration of tumors and inhibit tu...